journal article·2026-02

Amplifying ER Stress via Biodegradable Pseudo‐Conjugated Polymer Nanoparticles for Enhanced Sonodynamic Immunotherapy

Xiaowei Tong, Bingzheng Yu, Yajian Li, Meifang Shen, Tiejun Bing, Xiaomin Li, Haihua Xiao, Yingjie Yu

Advanced Functional Materials· Volume 36· Issue 13
Publisher page

Abstract

Abstract Sonodynamic therapy (SDT), which utilizes ultrasound (US) to activate sonosensitizers for generating reactive oxygen species (ROS), demonstrates significant potential in sonodynamic immunotherapy through triggering endoplasmic reticulum (ER) stress and subsequently activating immunogenic cell death (ICD). However, its clinical translation has been constrained by the poor biodegradability of most sonosensitizers. This study reports the first biodegradable pseudo‐conjugated polymeric sonosensitizer (PSP), exhibiting exceptional biodegradability and efficient ROS production. To further boost sonodynamic immunotherapy, a protein kinase R‐like endoplasmic reticulum kinase (PERK) inhibitor GSK2606414 (PERKi) is co‐assembled with PSP to form nanoparticles (PERKi NP). In a 4T1 cancer model, PERKi NP can generate substantial ROS to induce ER stress upon US irradiation. Notably, the generated ROS trigger the release of PERKi, which inhibit PERK pathway, thereby amplifying ER stress and ultimately activating ICD‐associated immune responses. Overall, PERKi NP offer a promising strategy for sonodynamic immunotherapy by amplifying ER stress to potentiate ICD‐mediated immune activation.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Ultrasound and Hyperthermia Applications · Photoacoustic and Ultrasonic Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

State Key Laboratory of Organic‐Inorganic Composites Beijing Laboratory of Biomedical Materials College of Life Science and Technology Beijing University of Chemical Technology Beijing 100029 China

Department of Urology Beijing Key Laboratory of Urologic Cancer Cell and Gene Therapy National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100021 China

Immunology and Oncology Center ICE Bioscience Beijing 100176 China

SINOPEC (Beijing) Research Institute of Chemical Industry Co., Ltd Beijing 100013 China

Beijing National Laboratory for Molecular Sciences Laboratory of Polymer Physics and Chemistry Institute of Chemistry Chinese Academy of Sciences Beijing 100190 China

Funding

Natural Science Foundation of Tianjin Municipal Science and Technology Commission · Key Technologies Research and Development Program of Anhui Province

References (70)

Show source-provided references
1. 10.1038/s41467-023-42509-710.1038/s41467-023-42509-7 ↗
2. Wang L. · Sci. Adv. · 2021 · 710.1126/sciadv.abj4796 ↗
3. 10.1126/science.adp720610.1126/science.adp7206 ↗
4. 10.1002/EXP.2021005810.1002/EXP.20210058 ↗
5. 10.1038/s41467-019-09760-310.1038/s41467-019-09760-3 ↗
6. 10.1016/j.nantod.2022.10145910.1016/j.nantod.2022.101459 ↗
7. 10.1002/adfm.20242556510.1002/adfm.202425565 ↗
8. 10.1002/smtd.20220042910.1002/smtd.202200429 ↗
9. 10.34133/bmef.006710.34133/bmef.0067 ↗
10. 10.1126/sciadv.adl047910.1126/sciadv.adl0479 ↗
11. 10.1038/s41467-023-39607-x10.1038/s41467-023-39607-x ↗
12. 10.1016/j.nantod.2022.10162110.1016/j.nantod.2022.101621 ↗
13. 10.1038/s41467-024-52489-x10.1038/s41467-024-52489-x ↗
14. 10.1016/j.cclet.2024.10964410.1016/j.cclet.2024.109644 ↗
15. 10.1038/s41467-022-31551-610.1038/s41467-022-31551-6 ↗
16. 10.1016/j.cclet.2024.10972710.1016/j.cclet.2024.109727 ↗
17. 10.1002/adma.20220659410.1002/adma.202206594 ↗
18. 10.1002/adma.20220969210.1002/adma.202209692 ↗
19. 10.1126/sciadv.adm956110.1126/sciadv.adm9561 ↗
20. 10.1039/D5CS00088B10.1039/D5CS00088B ↗
21. 10.1038/s41467-020-19970-910.1038/s41467-020-19970-9 ↗
22. 10.1002/adfm.20250127110.1002/adfm.202501271 ↗
23. 10.1016/j.cell.2016.11.04810.1016/j.cell.2016.11.048 ↗
24. Waldherr S. M. · Nat. Commun. · 2019 · 10 · 444310.1038/s41467-019-12070-3 ↗
25. 10.1016/j.actbio.2023.02.01210.1016/j.actbio.2023.02.012 ↗
26. 10.1126/sciadv.adk071610.1126/sciadv.adk0716 ↗
27. 10.1016/j.cell.2010.02.03410.1016/j.cell.2010.02.034 ↗
28. 10.1016/j.cell.2022.08.02510.1016/j.cell.2022.08.025 ↗
29. 10.1016/j.cell.2017.09.03410.1016/j.cell.2017.09.034 ↗
30. 10.1002/EXP.2023001910.1002/EXP.20230019 ↗
31. 10.1016/j.cell.2014.08.02510.1016/j.cell.2014.08.025 ↗
32. Jang J. · Blood · 2018 · 132 · 136010.1182/blood-2018-99-115814 ↗
33. Wang J. · Nat. Commun. · 2024 · 15 · 348110.1038/s41467-024-44745-x ↗
34. 10.1038/s41590-022-01145-x10.1038/s41590-022-01145-x ↗
35. Hughes D. T. · Sci. Signaling · 2020 · 1310.1126/scisignal.abb4749 ↗
36. 10.1002/adfm.20230701310.1002/adfm.202307013 ↗
37. 10.1002/adma.20210597610.1002/adma.202105976 ↗
38. 10.1002/adma.20220382010.1002/adma.202203820 ↗
39. Yu Y. · Adv. Mater. · 2023 · 3610.1002/adma.202402452 ↗
40. 10.1039/C7TB02570J10.1039/C7TB02570J ↗
41. 10.1038/s41467-024-53646-y10.1038/s41467-024-53646-y ↗
42. 10.1126/science.121148510.1126/science.1211485 ↗
43. Liang X. · Mol. Cancer · 2025 · 24 · 21910.1186/s12943-025-02375-x ↗
44. 10.1038/s41422-020-00416-210.1038/s41422-020-00416-2 ↗
45. Son J. · Cancer Res. · 2021 · 81 · 202910.1158/1538-7445.AM2021-2029 ↗
46. 10.1038/s41568-024-00674-x10.1038/s41568-024-00674-x ↗
47. 10.1016/j.trecan.2024.03.00310.1016/j.trecan.2024.03.003 ↗
48. 10.1038/s41590-022-01132-210.1038/s41590-022-01132-2 ↗
49. 10.1002/adma.20240497110.1002/adma.202404971 ↗
50. 10.1021/acsnano.3c1115410.1021/acsnano.3c11154 ↗
51. 10.1038/nri.2016.10710.1038/nri.2016.107 ↗
52. 10.1002/adma.20231045610.1002/adma.202310456 ↗
53. 10.1016/j.immuni.2021.04.00410.1016/j.immuni.2021.04.004 ↗
54. 10.1158/0008-5472.CAN-17-035710.1158/0008-5472.CAN-17-0357 ↗
55. Halaby M. J. · Sci. Immunol. · 2019 · 410.1126/sciimmunol.aax8189 ↗
56. 10.1016/j.cell.2016.12.02210.1016/j.cell.2016.12.022 ↗
57. 10.1016/j.cell.2019.02.01610.1016/j.cell.2019.02.016 ↗
58. 10.1002/advs.20241137810.1002/advs.202411378 ↗
59. 10.1016/j.cell.2022.09.02010.1016/j.cell.2022.09.020 ↗
60. 10.1002/adfm.20220537110.1002/adfm.202205371 ↗
61. 10.1002/adma.20240076210.1002/adma.202400762 ↗
62. 10.1038/s41467-021-25303-110.1038/s41467-021-25303-1 ↗
63. 10.1126/science.adg558510.1126/science.adg5585 ↗
64. 10.1002/adma.20187018210.1002/adma.201870182 ↗
65. 10.1126/science.abh247410.1126/science.abh2474 ↗
66. 10.1038/s41577-023-00838-010.1038/s41577-023-00838-0 ↗
67. 10.1038/s41467-022-33605-110.1038/s41467-022-33605-1 ↗
68. 10.1002/adma.20241880010.1002/adma.202418800 ↗
69. You K. · Science · 2021 · 37110.1126/science.abb6896 ↗
70. Mounir Z. · Sci. Signaling · 2011 · 4 · ra6210.1126/scisignal.2001630 ↗